Mitsubishi Tanabe Pharma America
Alejandro Salah, MD, PhD, MBA, MHA, BCMAS, is a Medical Director of Medical Affairs in the ALS division at Mitsubishi Tanabe Pharma America. Previously, Alejandro held the position of Medical Director of Medical Affairs in the Epilepsy division at Eisai US. Prior to that, Alejandro worked at NYU Langone Health at the NYU Comprehensive Epilepsy Center, where Alejandro was involved in various roles such as scientific consultant on Epilepsy R&I, clinical research coordinator, and coordinator of the Human Brain Epilepsy Tissue Bank. Alejandro has a diverse educational background, with degrees in Medicine, Neuroscience, and Business Administration. Their research interests include basic and translational neuroscience, electrophysiology, brain surgeries, and magnetoencephalography.
Mitsubishi Tanabe Pharma America
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, explore potential biomarkers to aid in further research and seek new answers. Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Please see our LinkedIn community guidelines here: http://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf